TANG KEVIN bought BOLD

November 5, 2026 · Form 4 insider transaction

TANG KEVIN bought 8,390 shares of Boundless Bio, Inc. at $2.40 per share, a transaction worth $20.1K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
8,390
Price
$2.40
Total value
$20.1K
InsiderTANG KEVIN
RoleOfficer, Director, 10% owner
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateNovember 5, 2026
Filing dateNovember 5, 2026
Shares owned after3,033,618
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

These shares were purchased in multiple transactions at prices ranging from $2.38 to $2.40.; Tang Capital Partners, LP ("TCP") beneficially owns 691,177 shares, Tang Capital Partners International, LP ("TCPI") beneficially owns 972,673 shares, Tang Capital Partners III, Inc. ("TCP III") beneficially owns 691,170 shares, and Tang Capital Partners IV, Inc. ("TCP IV") beneficially owns 678,598 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III and TCP IV, which are indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI, TCP III and TCP IV.

View the original Form 4 on SEC EDGAR